Behind the scenes at VIDO
In the first of a three-part series, Chris Carr speaks with VIDO CEO Dr. Volker Gerdts about how the facility has evolved since the pandemic.
Global News Morning Saskatoon
Jan 22
Zyus Life Sciences partnership with VIDO-InterVac
Zyus Life Sciences has teamed up with VIDO-InterVac to use plant cells to create a potential vaccine component for COVID-19 as an alternative to animals.
Global News Morning Saskatoon
May 13, 2020
Hospitals of Regina Foundation invests $150K in VIDO-InterVac lab
The director of the University of Saskatchewan’s VIDO-Intervac is celebrating a new investment in the lab.
Global News at 10 Regina
Jul 20, 2021
USask researchers expect human clinical trials for vaccine in the fall
University of Saskatchewan’s VIDO-InterVac team has seen promising results in their clinical trials for a COVID-19 vaccine.
Global News at 10 Regina
May 25, 2020
Update on VIDO-InterVac’s COVID-19 vaccine
VIDO-InterVac director and CEO Dr. Volker Gerdts joins Global Morning News to share the next steps in the process following a major milestone in their development of a potential COVID-19 vaccine.
Global News Morning Saskatoon
May 26, 2020
Saskatoon-made COVID-19 vaccine applying to start clinical trials
A day after the Pfizer COVID-19 vaccine was approved for use in Canada, VIDO-InterVac is hitting a milestone with their Saskatoon-made vaccine – filing an application to start human clinical trials.
Global News Morning Saskatoon
Dec 10, 2020
VIDO-InterVac takes steps forward in COVID-19 vaccine clinical trials
Saskatchewan researchers and scientists are stepping up to help Canada and the rest of the world get back to the way life was. Kyle Benning sits down with VIDO-InterVac’s director to discuss the progress of its homegrown vaccine.
Focus Saskatchewan
Mar 13, 2021
VIDO-InterVac is finding a vaccine for COVID-19
Director and CEO of VIDO-InterVac, Dr. Volker Gerdis, joins us to talk about how they are creating a vaccine.
Global News Morning Saskatoon
Mar 17, 2020
VIDO-InterVac receives $23.3M from feds in fight against COVID-19
The Vaccine and Infectious Disease Organization – International Vaccine Centre (VIDO-InterVac) is receiving $23.3 million in federal funding in the fight against COVID-19.
Global News at 10 Regina
Mar 23, 2020
The latest on campus with USask President Peter Stoicheff
USask President Peter Stoicheff joins Global News Morning with the latest on campus, including the changes to the winter semester due to the Omicron variant, and ongoing work at VIDO-InterVac.
Jan 24, 2022
Upgrades continue at VIDO-Intervac in Saskatoon
VIDO executive director Dr. Volker Gerdts provides an update on the current upgrades to the Saskatoon facility.
Politics
May 30, 2022
VIDO-InterVac on two years since first COVID cases in SK
VIDO-InterVac’s role was heightened two years ago as COVID-19 emerged. Director and CEO Dr. Volker Gerdts joins Global News Morning to look back at what’s changed, and looking towards the future.
Mar 15, 2022
VIDO-InterVac running vaccine trial in Africa as Omicron variant spreads
VIDO-InterVac director and CEO Dr. Volker Gerdts tells Global News Morning they are trialling their Saskatoon-made COVID-19 vaccine in Africa — and gives his thoughts on the Omicron variant.
Global News Morning Saskatoon
Nov 29, 2021
Latest on campus with USask president
University of Saskatchewan president Peter Stoicheff joins Global News Morning to talk about the latest on campus, including vaccination rates, VIDO-InterVac and Huskies Athletics.
Global News Morning Saskatoon
Oct 22, 2021
VIDO-InterVac update on COVID-19 antiviral funding, vaccine research
VIDO-InterVac director Dr. Volker Gerdts joins Global News Morning for an update on their COVID-19 vaccine research, along with recent funding for antiviral research.
Global News Morning Saskatoon
Oct 16, 2020
Update on VIDO-InterVac ferret testing
VIDO-InterVac has made progress with the testing of their coronavirus vaccine on ferrets. Dr. Volker Gerdts joins us to discuss the what the early results are dictating and when we should expect a potential vaccine.
Global News Morning Saskatoon
May 12, 2020
Ferrets, a Saskatoon lab and the leading edge of the race for a Coronavirus vaccine
Saskatoon’s VIDO-Intervac lab is getting ready to test a COVID-19 vaccine on living animals. Their test-creatures of choice: ferrets.
Global News at 10 Regina
Mar 5, 2020
VIDO-InterVac looking to expand to level 4 containment lab
VIDO-InterVac will be speaking to the city on their plans to expand to a level 4 containment lab, Executive Director and CEO Dr. Volker Gerdts joins Global News Morning with what that expansion means.
Jan 24, 2022
New vaccine facility opens in Saskatchewan
A major milestone for vaccine development in Saskatchewan, with a new manufacturing facility opening at the University of Saskatchewan. VIDO-Intervac is now one step closer to leading Canada’s vaccine development. Easton Hamm explains how this facility hopes to play a role in preventing future pandemics.
Global News at 5 Regina
Jun 29, 2022
VIDO-InterVac on new federal funding, vaccine trial
VIDO-InterVac Director and CEO Dr. Volker Gerdts joins Global News Morning to discuss where $59 million in federal funding will go to, along with an update on their vaccine trial.
Global News Morning Saskatoon
Apr 21, 2021